Cetaben

Cetaben is a PPARα-independent peroxisome proliferator. Cetaben is a non-fibrate hypolipidemic agent and potently reduces the concentration of cholesterol and triglycerides[1][2].

Product Specifications

CAS Number

[55986-43-1]

UNSPSC

12352005

Hazard Statement

H315, H319, H335

Target

PPAR

Type

Reference compound

Related Pathways

Cell Cycle/DNA Damage; Metabolic Enzyme/Protease; Vitamin D Related/Nuclear Receptor

Applications

COVID-19-immunoregulation

Field of Research

Cardiovascular Disease

Assay Protocol

https://www.medchemexpress.com/cetaben.html

Concentration

10mM

Purity

99.41

Solubility

DMSO : 25 mg/mL (ultrasonic)

Smiles

O=C(C1=CC=C(C=C1)NCCCCCCCCCCCCCCCC)O

Molecular Formula

C23H39NO2

Molecular Weight

361.56

Precautions

H315, H319, H335

References & Citations

[1]Chandoga J, et al. Cetaben and fibrates both influence the activities of peroxisomal enzymes in different ways. Biochem Pharmacol. 1994 Feb 9;47 (3) :515-9.|[2]Kovacs W, et al. Cetaben-induced changes on the morphology and peroxisomal enzymes in MH1C1 rat hepatomacells and HepG2 human hepatoblastoma cells. Histochem Cell Biol. 2001 Jun;115 (6) :509-19.